Phosphodiesterase Inhibitors

Phosphodiesterase Inhibitors, 1st Edition

Phosphodiesterase Inhibitors, 1st Edition,Clive Page,Christian Schudt,Gordon Dent,Klaus Rabe,ISBN9780122107207

Page   &   Schudt   &   Dent   &   Rabe   

Academic Press




248 X 191

Print Book + eBook

USD 234.00
USD 390.00

Buy both together and save 40%

Print Book


In Stock

Estimated Delivery Time
USD 200.00

eBook Overview

VST (VitalSource Bookshelf) format

DRM-free included formats : EPUB, Mobi (for Kindle), PDF

USD 190.00
Add to Cart

Key Features

@introbul:Key Features
@bul:* Utilizes actual testing and research of new PDE inhibitors
* Valuable for researchers and students alike


Non-selective inhibitors of cyclic nucleotide phosphodiesterase (PDE), such as theophylline, have been used extensively since 1958. In the decade of the '70s, various PDE isoenzymes were defined which led to the development of the second generation of PDE inhibitors. Currently a variety of these new inhibitors are under test as potential anti-inflammatory drugs. During the past five years, molecular biology has revealed a superfamily of these phosphodiesterase isoenzymes. This book summarizes the present state of knowledge, as well as giving a comprehensive description of the compounds available. It will be invaluable for everyone who wants to choose the most suitable PDE inhibitor for their research or who is dealing with such drugs in a clinical setting.


Research level pharmacologists, immunologists, and cell biologists; as a reference text in this area for those involved in degree-level teaching. Pharmaceutical companies.

Clive Page

Affiliations and Expertise

King's College London, U.K.

View additional works by Clive Page

Christian Schudt

Affiliations and Expertise

Byk Gulden Pharmaceuticals, Konstan, Germany

Gordon Dent

Affiliations and Expertise

Kraankenhaus Grobhansdorf, Zentrum fur Pneumologie und Thoraxchirurgie, Grobhansdorf, Germany

Klaus Rabe

Affiliations and Expertise

Kraankenhaus Grobhansdorf, Zentrum fur Pneumologie und Thoraxchirurgie, Grobhansdorf, Germany

Phosphodiesterase Inhibitors, 1st Edition

K.M. Ferguson and K. Loughney, Identification and Quantification of PDE Isoenzymes and Subtypes by Molecular Biological Methods.
H. Tenor and C. Schudt, Analysis of PDE Isoenzyme Profiles in Cells and Tissues by Pharmacological Methods.
K.F. Rabe, Effects of Theophylline and Nonselective Xanthine Derivatives on PDE Isoenzymes and Cellular Function.
R.K. Sharma, Interaction of PDE I Inhibitors with Isoenzymes and Cell Functions.
R. Fischmeister, EHNA as an Inhibitor of PDE II.
V.C. Manganiello, PDE II Inhibitors as Therapeutic Agents.
M.A. Giembycz, Interaction of PDE IV Inhibitors with Enzymes and Cell Functions and their Therapeutic Potential.
P.J. Silver, Inhibition of PDE Isoenzymes and Cell Function by Selective PDE V Inhibitors.
J.D. Corbin, Design and Synthesis of Xanthines and Cyclic GMP Analogues as Potent Inhibitors of PDE V and PDE I.
A. Hatzelmann, Enzymatic and Functional Inhibition of Dual-Selective Inhibitors.
R. Alvarez, Subtype Selectivity, Inhibition of Cell Function and Therapeutic Potential of RS 25344.
J.E. Souness, Characterization of Different States of PDE IV by Rolipram and RP 73401.
T.J. Torphy, Functional Significance of Two Sites for Inhibitors at PDE IV.
Subject Index.
Free Shipping
Shop with Confidence

Free Shipping around the world
▪ Broad range of products
▪ 30 days return policy

Contact Us